StockData
enVVeno Medical Corp logo

enVVeno Medical Corp (NVNO) stock

NVNONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 6/30
$5.77+0.00 (0.00%)

Close on Nov 18, 2026Market cap $4.01MP/E –Yield –

enVVeno Medical operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

enVVeno Medical's operating income for the twelve months ending Sep 30, 2026 was -$16.41M. For fiscal 2025 it was -$20.90M. The highest annual figure on record is -$6.10M in fiscal 2017.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$20.90M–
FY2024Dec 31, 2024-$23.83M–
FY2023Dec 31, 2023-$25.24M–
FY2022Dec 31, 2022-$24.93M–
FY2021Dec 31, 2021-$16.89M–
FY2020Dec 31, 2020-$9.14M–
FY2019Dec 31, 2019-$7.68M–
FY2018Dec 31, 2018-$7.85M–
FY2017Dec 31, 2017-$6.10M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$4.53M–
Q2 FY2026Jun 30, 2026-$3.80M–
Q1 FY2026Mar 31, 2026-$4.06M–
Q4 FY2025Dec 31, 2025-$4.01M–
Q3 FY2025Sep 30, 2025-$4.88M–
Q2 FY2025Jun 30, 2025-$7.05M–
Q1 FY2025Mar 31, 2025-$4.95M–
Q4 FY2024Dec 31, 2024-$6.70M–
Q3 FY2024Sep 30, 2024-$6.17M–
Q2 FY2024Jun 30, 2024-$5.45M–
Q1 FY2024Mar 31, 2024-$5.50M–
Q4 FY2023Dec 31, 2023-$6.28M–
Q3 FY2023Sep 30, 2023-$5.35M–
Q2 FY2023Jun 30, 2023-$6.81M–
Q1 FY2023Mar 31, 2023-$6.80M–
Q4 FY2022Dec 31, 2022-$6.46M–
Q3 FY2022Sep 30, 2022-$6.15M–
Q2 FY2022Jun 30, 2022-$6.99M–
Q1 FY2022Mar 31, 2022-$5.34M–
Q4 FY2021Dec 31, 2021-$8.99M–
Q3 FY2021Sep 30, 2021-$2.71M–
Q2 FY2021Jun 30, 2021-$2.39M–
Q1 FY2021Mar 31, 2021-$2.81M–
Q4 FY2020Dec 31, 2020-$4.16M–
Q3 FY2020Sep 30, 2020-$1.92M–
Q2 FY2020Jun 30, 2020-$1.55M–
Q1 FY2020Mar 31, 2020-$1.51M–
Q4 FY2019Dec 31, 2019-$2.30M–
Q3 FY2019Sep 30, 2019-$1.83M–
Q2 FY2019Jun 30, 2019-$1.96M–
Q1 FY2019Mar 31, 2019-$1.58M–
Q4 FY2018Dec 31, 2018-$1.80M–
Q3 FY2018Sep 30, 2018-$1.49M–
Q2 FY2018Jun 30, 2018-$3.11M–
Q1 FY2018Mar 31, 2018-$1.46M–
Q4 FY2017Dec 31, 2017-$1.93M–
Q3 FY2017Sep 30, 2017-$1.81M–
Q2 FY2017Jun 30, 2017-$1.23M–

More enVVeno Medical figures

See a number that looks wrong?